LINCOSPECTIN® STERILE SOLUTION
LINCOSPECTIN® STERILE SOLUTION
Authorised
- Lincomycin
- Spectinomycin
Product identification
Medicine name:
LINCOSPECTIN® STERILE SOLUTION
Active substance:
- Lincomycin
- Spectinomycin
Target species:
-
Chicken
-
Pig
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Lincomycin50.00/milligram(s)1.00millilitre(s)
-
Spectinomycin100.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Oral use
-
Chicken
-
Meat and offal5dayΔεν επιτρέπεται η χρήση σε πτηνά τα οποία παράγουν αυγά για ανθρώπινη κατανάλωση, συμπεριλαμβανομένων των νεοσσών αντικατάστασης που προορίζονται για την παραγωγή αυγών για ανθρώπινη κατανάλωση.
Τα ζώα δεν πρέπει να σφάζονται για ανθρώπινη κατανάλωση κατά τη διάρκεια της θεραπείας.
-
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF52
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Available in:
-
Cyprus
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - known active substance (Article 8 of Regulation (EU) 2019/6)
Marketing authorisation holder:
- Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- 18288
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 14/07/2022
